RAC and NEU

Let me start off by saying I’m no expert in buying shares or reading charts. I invested in RAC due to Wombat who was also very active in property investing which is an area I have more experience. But his upbeat thoughts and his knowledge led me to invest in RAC a few years ago. Yes I’m also in the red. Despite the current share price and some of the issues RAC has experienced over the last few years including some changes in direction the basic evidence about RAC and it’s potential hasn’t changed and in fact has strengthened. Congratulations to those who hold NEU which has shown a gradual increase in its share price in the past 2 years and especially since the recent positive phase 2 results in Phelan-McDermid Syndrome which is a rare genetic condition. I cant help but think if this result in a phase 2 trial in a rare genetic condition lifts the share price to over $26 what would a positive phase 2 result by RAC in cancers. It gives me some hope that we can see a rise like this and hopefully a great deal more. Back in April 2021 NEU was trading at $1.33 RAC was $3.38. Now NEU is trading over $26. Again I’m no expert but geez would that be good to see a rise like this with RAC (and more hopefully) especially with all the possibilities of RAC. Can you imagine how quickly big Pharms would try to get get in on it once results were out? Interested to hear others thoughts on this.